Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

被引:47
|
作者
Kato, Tomoko S. [1 ]
Takayama, Hiroo [2 ]
Yoshizawa, Saeko [3 ]
Marboe, Charles [3 ]
Schulze, P. Christian [1 ]
Farr, Maryjane [1 ]
Naka, Yoshifumi [2 ]
Mancini, Donna [1 ]
Maurer, Mathew S. [1 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 04期
关键词
MUSCLE CELL DISORGANIZATION; LEFT-VENTRICULAR HYPERTROPHY; HEART-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; ATHLETES HEART; SURVIVAL; PREVALENCE; INFECTION; DIAGNOSIS; FEATURES;
D O I
10.1016/j.amjcard.2012.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac transplantation is a treatment option for patients with hypertrophic cardiomyopathy (HC) who developed refractory heart failure and/or intractable arrhythmia. However, the pretransplant characteristics and post-transplant prognosis for patients with nondilated idiopathic HC has not yet fully elucidated. Therefore, we retrospectively reviewed 813 consecutive transplant recipients undergoing cardiac transplantation at Columbia University Medical Center from 1999 to 2010 and compared the clinical course of 41 patients with idiopathic HC with that of 373 patients with ischemic heart disease and 398 patients with other heart disease. The patients with HC were younger than those with ischemic heart disease (47.8 +/- 14.0 vs 57.1 +/- 9.4 years; p <0.0001). The proportion of patients undergoing ventricular assist devise surgery for bridge-to-transplant was lower in patients with HC than in those with ischemic heart disease or other heart disease (14.6% vs 31.1% vs 35.7%, all p <0.01). The post-transplant survival of those with HC was better than that for those with ischemic heart disease (90.1% vs 85.8% and 83.9% vs 67.1% at 1 and 5 years, respectively; p = 0.0359), although it was not significantly different from those with other heart disease. Proportional hazards analysis revealed that the subjects with HC had reduced post-transplant mortality (hazard ratio 0.4760, 95% confidential interval 0.1889 to 0.9762; p = 0.042) on univariate, but not multivariate, analysis. Most patients with HC had nondilated left ventricles (left ventricular end-diastolic dimension <= 55 mm; n = 27), and post-transplant survival did not differ from that for those with dilated left ventricles (left ventricular end-diastolic dimension >55 mm; n = 14). In conclusion, the post-transplant survival of those with HC did not differ from those of the subjects who underwent transplant for other non-HC indications. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:568-574)
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [21] Effect of sildenafile in patient with obstructive hypertrophic cardiomyopathy candidated to cardiac transplantation
    Farrais Villalba, Marcos
    Ruiz Cano, Maria Jose
    Delgado Jimenez, Juan
    Escribano Subias, Pilar
    MEDICINA CLINICA, 2009, 133 (15): : 602 - 603
  • [22] Cardiac resynchronization treatment in a patient with hypertrophic cardiomyopathy after heart transplantation
    Vural, Ahmet
    Ertas, Gokhan
    Agacdiken, Aysen
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 (01): : 72 - 74
  • [23] Cardiac transplantation in hypertrophic cardiomyopathy in the united states: 2003-2011
    Singh, A.
    Agrawal, S.
    Pakniyat, S.
    Randhawa, S.
    Saluja, S.
    Nanda, S.
    Shirani, J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1014 - 1014
  • [24] Heart transplantation in hypertrophic cardiomyopathy
    Biagini, Elena
    Spirito, Paolo
    Leone, Ornella
    Picchio, Fernando M.
    Coccolo, Fabio
    Ragni, Luca
    Lofiego, Carla
    Grigioni, Francesco
    Potena, Luciano
    Rocchi, Guido
    Bacchi-Reggiarn, Letizia
    Boriani, Giuseppe
    Prandstraller, Daniela
    Arbustini, Eloisa
    Branzi, Angelo
    Rapezzi, Claudio
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (03): : 387 - 392
  • [25] Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy
    Harley, ID
    Jones, EF
    Liu, G
    McCall, PR
    McNicol, PL
    BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (05) : 675 - 677
  • [26] Intraoperative Management of Liver Transplantation in Patients with Hypertrophic Cardiomyopathy: A Review
    Robertson, A.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (05) : 1721 - 1723
  • [27] Outcomes of hypertrophic cardiomyopathy patients undergoing non-cardiac surgery: A cohort study with matched non hypertrophic cardiomyopathy patients
    Dhillon, A.
    Khanna, A.
    Randhawa, M.
    Cywinski, J.
    Saager, L.
    Thamilarasan, M.
    Lever, H. M.
    Desai, M. Y.
    EUROPEAN HEART JOURNAL, 2015, 36 : 178 - 178
  • [28] Prevalence and Characteristics of Hypertrophic Cardiomyopathy Phenotype in Patients with Cardiac Sarcoidosis
    Zia, Abdul
    Lal, Mallika
    Nazer, Babak
    Levin, Benjamin
    Masri, Ahmad
    CIRCULATION, 2024, 150
  • [29] Cardiac troponin T mutations in Chinese patients with hypertrophic cardiomyopathy
    Wu, HF
    Yang, D
    Wan, WH
    Bian, ZP
    Xu, JD
    Ma, WZ
    Zhang, JN
    CHINESE MEDICAL JOURNAL, 2004, 117 (06) : 944 - 946
  • [30] UTILITY OF CARDIAC MAGNETIC RESONANCE IMAGING IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    Mangalindan, Kristin
    Hulten, Edward
    Woods, Kevin
    Lichtenberger, John
    Peterson, Paul G.
    Hood, Maureen
    Ho, Vincent
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S631 - S631